BackClearPoint Neuro Overview

ClearPoint Neuro Current Cash

ClearPoint Neuro's current cash is $29M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$29.36M
↓ 29.32% YoYΔ $-12.18M vs prior year quarter

Peer trimmed avg / median

Loading

ClearPoint Neuro Current Cash History

Loading

ClearPoint Neuro vs. peers: Current Cash Comparison

Loading

ClearPoint Neuro Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ClearPoint Neuro (CLPT) FAQ

ClearPoint Neuro (CLPT) currently reports a current cash of $29M as of June 2026. That compares with $42M in the prior-year period — down 29.3% year over year. Use the charts on this page to explore ClearPoint Neuro's current cash history and peer comparisons.

ClearPoint Neuro's current cash decreased from $42M to $29M — a 29.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ClearPoint Neuro reported $29M in current cash as of June 2026. That compares with $42M in the prior-year period — down 29.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ClearPoint Neuro, and consider following CLPT for alerts when major investors trade the stock.

ClearPoint Neuro is classified in the Healthcare sector. On current cash, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLPT with unrelated industries.